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AbstrACt
Objective To evaluate changes in awareness of maternal 
sepsis among healthcare providers resulting from the 
WHO Global Maternal Sepsis Study (GLOSS) awareness 
campaign.
Design Independent sample precampaign/postcampaign 
through online and paper- based surveys available for over 
30 days before campaign roll- out (pre) and after study 
data collection (post). Descriptive statistics were used for 
campaign recognition and exposure, and odds ratio (OR) 
and percentage change were calculated for differences in 
awareness, adjusting for confounders using multivariate 
logistic regression.
setting and participants Healthcare providers from 398 
participating facilities in 46 low, middle and high- income 
countries.
Intervention An awareness campaign to accompany 
GLOSS launched 3 weeks prior to data collection and 
lasting the entire study period (28 November 2017 to 15 
January 2018) and beyond.
Main outcome measures Campaign recognition and 
exposure, and changes in awareness.
results A total of 2188 surveys were analysed: 1155 
at baseline and 1033 at postcampaign. Most survey 
respondents found the campaign materials helpful (94%), 
that they helped increase awareness (90%) and that 
they helped motivate to act differently (88%). There were 
significant changes with regard to: not having heard of 
maternal sepsis (−63.4% change, pre- OR/post- OR 0.35, 
95% CI 0.18 to 0.68) and perception of confidence in 
making the right decisions with regard to maternal sepsis 
identification and management (7.3% change, pre- OR/
post- OR 1.44, 95% CI 1.01 to 2.06).
Conclusions Awareness raising campaigns can 
contribute to an increase in having heard of maternal 
sepsis and an increase in provider perception of 
confidence in making correct decisions. Offering the 
information to make accurate and timely decisions while 
promoting environments that enable self- confidence and 
support could improve maternal sepsis identification and 
management.
IntrODuCtIOn
The global health community has recently 
drawn attention to the importance of 
sepsis and its toll on global mortality and 
morbidity.1–3 In 2017, the World Health 
Assembly approved a resolution on sepsis 
to improve the prevention, diagnosis and 
management of sepsis.4 With updates in 2017 
and 2018, the Surviving Sepsis Campaign has 
been developing guidelines for management 
and recommended bundles of care for sepsis 
among adult populations, not specific to 
pregnant or recently pregnant women, since 
2002.5–7
strengths and limitations of this study
 ► This study presents the results of an evaluation of 
a global awareness campaign which accompanied 
a research study on maternal infections and sepsis.
 ► This evaluation was a cost- effective, feasible way in 
which to assess campaign effectiveness among a 
varied and global population of healthcare providers.
 ► Our precampaign/postcampaign using anonymous 
surveys with no control group does not allow to dis-
cern the impact of the campaign alone or matching 
precampaign and postcampaign responses.
 ► Campaign fidelity was only assessed through health-
care provider self- report at postcampaign surveys.
 ► This evaluation was restricted to the duration of the 
study follow- up period limiting understanding of 
long- term impact.
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box 1 Actions and components for the STOP SEPSIS! awareness campaign
 ► Select a campaign lead. A campaign lead was selected to coordinate and assist with the development of the campaign strategy and execution, and 
evaluation plan at a global level. This person ensured execution of each of the steps, supported the communication company and the study country 
coordinators in the participating countries who interacted with the providers working in the participating facilities.
 ► Agree on a budget to fund the campaign. Funds were necessary to cover the costs of the campaign lead, the communication company and support 
to countries for printing of materials. The cost of this campaign was US$200 000.
 ► Seek the assistance of health and media communication experts. A communication company with expertise in global health was contracted to lead 
the design and development of the Global Maternal Sepsis Study (GLOSS) campaign concept and look.
 ► Decide on the minimum set of materials and activities to be developed and implemented. With input from people in the field who would be targeted 
through the campaign, the decision to have posters, infographics, press release and other presentation templates, social media messaging and a 
website was agreed on. In addition, a global congress was conceived in collaboration with partners from the Global Sepsis Alliance.
 ► Develop campaign messaging, image and logo. A main message, tagline and logo were designed with assistance from the communication company, 
content experts in maternal sepsis and country/regional coordinators for GLOSS.
 ► Develop an evaluation plan. Given the breadth and geographical extent of the campaign’s target population an online survey was used to collect 
providers’ knowledge, attitudes, practices at baseline and postcampaign, including additional measures of campaign recognition and exposure at 
postcampaign. Paper- based surveys were used on demand.
 ► Support the printing and upkeep of materials. The campaign lead coordinated translation of all materials into five United Nations (UN) official languag-
es and three additional languages as per GLOSS country coordinators’ request. Participating countries were provided with funds needed to print the 
posters and infographics. Campaign lead was also in charge of regular upkeep of the dedicated website which includes timely news stories.
 ► Implement the campaign. This included:
 – World Sepsis Congress (WSC) Spotlight. A free, online congress focusing specifically on maternal and neonatal sepsis offered in collaboration with 
the Global Sepsis Alliance (https://wscspotlight.org/). The 25 presentations given over four sessions were later made available as YouTube videos 
and podcasts for free, with subtitles in multiple languages.
 – Website. A dedicated website used both as a repository of campaign materials for free download and to disseminate news about the study (http://
srhr.org/sepsis).
 – Print materials. Posters with information about the study and infographics on maternal sepsis prevention, and identification and management to be 
displayed in different areas where women with suspected or confirmed infection could be found (eg, labour ward, patient waiting area).
 – Press releases. Templates for announcing the objectives of the study and the campaign; countries/facilities were encouraged to engage local 
media for this purpose.
 – Social media. Campaign messaging disseminated and multiplied using social media through HRP’s Twitter platform (@HRPresearch).
 ► Expand the effect of the campaign. Countries were encouraged to take ownership over the campaign and develop additional materials and organise 
activities prior to the start of study data collection.
Infections and sepsis remain the major causes of death 
and disability among women during pregnancy, child-
birth, postpartum and post- abortion.8 9 To respond to 
this, the Global Maternal and Neonatal Sepsis Initiative 
was launched in 2016.4 10 Building on the 2016 SEPSIS-3 
definition,11 the World Health Organization (WHO) led 
the development of a definition for maternal sepsis as ‘a 
life- threatening condition defined as organ dysfunction 
resulting from infection during pregnancy, childbirth, 
postpartum, and post- abortion’.12 And in 2017, WHO led 
the Global Maternal Sepsis Study (GLOSS) and Aware-
ness Campaign to assess the burden of maternal infec-
tions and sepsis, to validate identification criteria for 
possible severe maternal infection and maternal sepsis 
and to raise awareness on maternal sepsis among health-
care providers working in study participating facilities.13
Awareness raising has mostly been attempted through 
campaigns. These have been implemented to increase 
knowledge, improve attitudes or change behaviours 
around different health issues.14–16 Specific to sepsis, the 
UK Sepsis Trust heads a campaign on sepsis since 2012 
and the Global Sepsis Alliance leads efforts aimed at 
raising sepsis awareness since 2010.17 18 However, neither 
of these two large campaigns have been specific to 
maternal sepsis and to our knowledge neither has been 
thoroughly evaluated to assess for impact in increasing 
awareness.
This evaluation looked at recognition and exposure to 
the GLOSS campaign materials and changes in provider 
awareness of maternal sepsis after campaign implemen-
tation. The latter included changes in knowledge on 
maternal sepsis and perception of enabling environ-
ments for identification and management of maternal 
sepsis.
MethODs
The GLOSS campaign was designed to accompany the 
Global Maternal Sepsis Study with the goal of raising 
awareness on maternal sepsis among healthcare providers 
working in participating facilities. Details regarding study 
protocol, including selection of countries and facili-
ties, were published elsewhere.13 In short, GLOSS was 
a facility- based, 1- week inception cohort study which 
enrolled pregnant or recently pregnant women with 
suspected or confirmed infection at 713 healthcare facil-
ities in prespecified geographical areas located in 52 low, 
middle and high- income countries.13
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Figure 1 Countries eligible for the Global Maternal Sepsis 
Study (GLOSS) ‘STOP SEPSIS!’ awareness campaign 
evaluation (n=46). 
Color key: teal: countries included in the GLOSS STOP 
SEPSIS! awareness campaign evaluation (N=37); green: 
countries eligible for the evaluation but excluded from this 
analysis because less than 2 responses received (N=9) 
The boundaries shown on this map do not imply the 
expression of any opinion whatsoever on the part of WHO 
concerning the legal status of any country, or concerning the 
delimitation of its frontiers or boundaries
Table 1 Characteristics of respondents and the facilities in 








n % n %
Age (years) 1147 1020
  <31 354 31 301 30
  31–40 389 34 407 40
  >40 404 35 312 31
Sex 1153 1022
  Male 287 25 223 22
  Female 866 75 799 78
Qualification 1151 1025
  Nurse/auxiliary nurse/
midwife
440 38 456 44
  Physician 561 49 456 44
  Resident 150 13 113 11
Years of work experience 1107 970
  <10 541 49 476 49
  10–20 349 32 320 33
  >20 217 20 174 18
Region 1155 1033
  Africa 224 19 226 22
  Asia 173 15 170 16
  Eastern Mediterranean 171 15 165 16
  Europe† 137 12 97 9
  Latin America 450 39 375 36
Level of the facility in which 
respondent works
1153 1033
  I 127 11 166 16
  II 236 20 258 25
  III 790 69 609 59
Respondent worked in a 
public facility*
1154 1033
  Yes 937 81 928 90
  No 217 19 105 10
Country implemented 
an expanded version of 
campaign*
1155 1033
  Yes 705 39 533 52
  No 450 61 500 48
*P<0.05.
†Includes countries in Central Asia (Kazakhstan, Kyrgyzstan and 
Tajikistan), in line with WHO regions.
the stOP sePsIs! awareness campaign
The campaign launch was planned for before study 
implementation continuing throughout data collection 
and beyond. It was designed using existing frameworks 
for public information campaigns, social marketing, 
health communication and behaviour change.14 19–21 
The development of the campaign included an overar-
ching communication strategy using a multicomponent 
approach delivering a simple and consistent message 
through visually attractive media.22
The campaign had a soft launch with an online congress 
on 12 September 2017 and the full campaign roll- out 
began on 6 November 2017, which included a website, 
printed materials, social media messaging and press 
releases. While global coordination of the campaign was 
undertaken by WHO, implementation of the campaign 
was the remit of GLOSS country coordinators. Box 1 
describes the different actions and components that were 
necessary for the design and development of the STOP 
SEPSIS! awareness campaign.
evaluation of the stOP sePsIs! awareness campaign
We used an independent sample precampaign/postcam-
paign design through online and paper- based surveys. 
Details regarding the definition used for awareness for 
this campaign, survey formulation and dissemination, 
including analysis of baseline data, have been published 
elsewhere.23 Briefly, a precampaign 32- question survey 
was developed to gather baseline information on health-
care providers’ awareness of maternal sepsis through 
self- reported knowledge on maternal sepsis and percep-
tion of their work environments as enabling for the 
identification and management of maternal sepsis. 
Knowledge was assessed through questions relating to 
whether respondents had heard of maternal sepsis, 
correct identification of criteria that define maternal 
sepsis (infection plus organ dysfunction) and identifi-
cation of correct initial management of maternal sepsis 
and infections (antibiotics and fluids) when maternal 
sepsis was suspected in the case vignette presented in the 
survey. Perception of enabling environments was assessed 
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Figure 2 Measures of campaign exposure in percentages (n=1033).
through self- reported confidence in making right deci-
sions, reported availability of resources for correct iden-
tification and management, and feeling of support from 
their work environments in dealing with maternal sepsis, 
using a 5- point Likert scale. The same survey was admin-
istered at postcampaign to assess changes in knowledge 
and perception of their environments; 14 additional 
questions were included in the postsurvey which consid-
ered respondents’ recognition of and exposure to the 
campaign, such as knowledge about the study and the 
campaign, message recall, engagement with social media 
for the campaign and whether the campaign materials 
prompted changes in behaviour. See online supplemen-
tary appendix 1 for a copy of the surveys.
Eligible respondents were healthcare providers 
working in GLOSS participating facilities in countries 
that received financial support for campaign implemen-
tation (n=46); we excluded all surveys from respondents 
that did not explicitly state that they were providers caring 
for women with infections in healthcare facilities (eg, 
hospital administrators, or community health workers, or 
if the field was left blank) and from countries with less 
than two responses at either precampaign or postcam-
paign (n=9). See figure 1 for a map of all the countries 
eligible for this evaluation. The surveys were distributed 
using a snowballing technique and were available in seven 
languages: Arabic, English, French, Portuguese, Russian, 
Spanish and Vietnamese. The surveys were available for 
over 30 days (precampaign between 29 September and 5 
November 2017, postcampaign between 31 January and 
11 March 2018). Weekly reminders were sent through the 
online tool and via email to non- respondents. Targeted 
outreach was undertaken in countries with fewer than 
two responses. The campaign was active between 6 
November 2017 and 15 January 2018; however, countries 
were encouraged to continue to use the materials beyond 
GLOSS study implementation.
Data analysis
We used descriptive analysis to provide frequencies and 
percentages for the characteristics of the sample, knowl-
edge and perceived enabling environments and for all the 
questions relating to campaign recognition and exposure. 
The latter were assessed through postcampaign surveys 
only and complemented with self- reported accounts by 
GLOSS country coordinators. Text- based responses were 
codified into numerical values according to common 
emerging themes. All Likert scale answers were dichoto-
mised assigning a 1 to the two most favourable responses 
(ie, they felt very or somewhat confident about making the 
right decision) and 0 to the combination of remaining 
options (neutral, not very confident or not confident at all). 
While previously we assessed dichotomisation using 1 to 
the single most favourable response (ie, respondent felt 
very confident) and a 0 to the combination of remaining 
options (somewhat confident, neutral, not very confident or 
not confident at all)23 we decided to include a more flex-
ible definition of confidence, perception of availability 
of resources and feeling of support to allow for a more 
robust denominator that would enable comparisons. 
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Figure 3 Responses when answering Yes to the question ‘Did the information provided in the materials motivate you to do 
something differently than before?’ (n=658). 
(Respondents were able to check as many response options as needed.)
See online supplementary appendix 2 for results of the 
overall analysis using this second dichotomisation not 
used in this evaluation.
To assess the impact of the campaign we conducted 
several analyses. First, we calculated percentage change 
([(% in post − % in pre)/% in pre]×100) and estimated 
ORs to determine differences in respondent knowl-
edge and perception of enabling environments after 
campaign implementation relative to baseline measure 
for the total sample and by respondent characteristics. 
Due to the methodology used for survey dissemination 
and anonymity of surveys, this was not a matched sample, 
paired response precampaign/postcampaign. Sensi-
tivity analyses were conducted restricting the population 
to facilities from which we received at least one survey 
response and at least two responses, and to countries with 
more than 30 survey responses per country at precam-
paign and at postcampaign.
Second, we used multivariate logistic regression 
models to explore the association between respondents 
and facilities’ characteristics at precampaign and post-
campaign and change in components of awareness after 
campaign implementation. Based on analysis of baseline 
data and our assumptions on characteristics that would 
be associated with levels of awareness,23 we included 
the following variables in the model: whether respon-
dent was a physician, years of work experience, region 
where the respondent worked, whether the country had 
implemented an expanded version of the campaign and 
whether the facility was a level III facility. Countries were 
considered to have implemented an expanded version 
of the campaign if they had printed and displayed all 
posters and infographics, prepared and disseminated 
press releases and if they had organised other activities 
or developed other materials for the campaign. Since 
less than 20% of respondents participated in the World 
Sepsis Congress Spotlight we did not include this vari-
able in our models. We looked at effect modification by 
examining interactions between the time of the survey 
(precampaign or postcampaign) and each of the charac-
teristics included in the model.
We used Pearson’s χ2 test to compare proportions 
and Wald’s test to assess for significant differences in 
the models including interaction terms. Logistic regres-
sion analysis was used to estimate ORs between pre- and 
post-, crude and adjusted, clustering at the geograph-
ical area level. Statistical significance is reported at 
p<0.05. Stata (V.14.2, College Station, TX) was used for 
the analyses.
Patient and public involvement
This research was done without patient or public involve-
ment. While the development of the campaign was done 
with input from study regional and country coordinators, 
respondents to the surveys were not invited to comment 
on the study design or to contribute to the writing of this 
manuscript given their anonymity.
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box 2 Accounts from the field*
Implementation of the campaign changed the way the city’s providers 
acted. First, it helped in bridging the gap between academics and pro-
viders, which, in turn, helped motivate the entire staff around the study. 
The campaign helped us all feel more committed with the study. And, 
most importantly, it helped shed light on a problem (maternal sepsis) 
that we hadn’t made public before. (Cali, Colombia)
In (our) facility there was already a protocol for sepsis early recognition, 
but the campaign, as well as the study made it come alive again. Sepsis 
was on everyone’s eyes and mouths. The teams were very permeable 
to knowledge and eager to recognize and treat sepsis immediately. 
(Campinas, Brazil)
Participation in the campaign allowed me to see that we can find cas-
es of maternal sepsis in the most diverse locations in a facility. And 
that invariably the most complex cases were those resulting from a 
condition that was neglected or treated incorrectly/untimely. (Maputo, 
Mozambique)
Despite having some protocols in place, during the campaign and study 
we realized that these were not sufficient to detect women with in-
fection. This campaign was very important and helped us find a lot of 
cases that might have been missed otherwise (…) We are planning on 
improving reporting mechanisms of any suspected cases and support-
ive supervision and surveillance as a result of this study. (Ulaanbaatar, 
Mongolia)
As a result of our participation in GLOSS [Global Maternal Sepsis Study], 
we actually committed as a Program in our 2017 Maternal Death 
Review Forum to eliminate maternal sepsis as a cause of maternal 
death. (Manila, Philippines)
(Since implementing the GLOSS awareness campaign at a national lev-
el, we noticed that) we have prioritized the identification and suspicion 
of maternal and neonatal sepsis in all level I facilities, in specialized 
hospital care, and in the public health agenda. (Mexico City, Mexico)
*These reports first appeared in a blog post on the Merck for Mothers website 
in April 2018: https://www.msdformothers.com/blog/assessing-addressing-
maternal-sepsis.html and in a news story on WHO/HRP’s website in September 
2018: https://www.who.int/reproductivehealth/maternal-sepsis-mexico/en/
role of the funding source
The funders of the study had no role in study design, data 
collection, data analysis, data interpretation or writing of 
this original article.
results
A total of 2188 surveys met our inclusion criteria. Of 
these, 1155 from 192 facilities were received at baseline 
and 1033 from 196 facilities at postcampaign. There were 
no significant differences in sociodemographic charac-
teristics between respondents at precampaign and post-
campaign surveys, except for a higher proportion of 
respondents working in a public facility at postcampaign 
and a higher proportion of respondents from countries 
where an expanded version of the campaign was imple-
mented (table 1). Responses came from the same coun-
tries at precampaign and postcampaign. Because of the 
technique used for survey dissemination and because we 
did not know the total population of potentially exposed 
healthcare providers working in GLOSS participating 
facilities (provider turnover, rotation and replacements 
are high), we were unable to calculate a response rate. 
However, since the campaign was implemented equally at 
the geographical area level, if providers remained within 
the study area they would have been exposed to the 
campaign. Results from the sensitivity analyses showed 
that overall findings in the subgroups considered were 
consistent with the results from the complete sample 
(online supplementary appendix 3); for this reason, we 
used the entire sample for all subsequent analyses.
We first present the results relating to campaign recog-
nition and exposure and then results relating to changes 
in knowledge and perception of respondents’ work 
environments.
Campaign recognition and exposure
Campaign recognition and exposure were high among 
most of the postcampaign survey respondents. Seventy- six 
per cent of respondents stated they noticed the materials 
in their facilities; among those, 94% reported finding the 
materials helpful, 90% that the materials helped increase 
awareness on maternal sepsis and 88% that the materials 
motivated them to do something differently. Only 8% of 
respondents had used Twitter to amplify the message of 
the campaign (figure 2). Among respondents who stated 
that the information provided in the materials motivated 
them to do something differently than before, 84% stated 
that it motivated them to suspect maternal sepsis and 78% 
to act fast (figure 3). Among respondents stating that the 
materials had not motivated them to do anything differ-
ently, 45% said it was because they already knew about 
maternal sepsis identification and management while 
12% stated they had not seen the campaign materials.
Country coordinators shared anecdotal experiences 
of increased awareness in their facilities and the imple-
mentation of changes in practice and policies because of 
the study and the campaign. These accounts speak of a 
broader engagement with maternal sepsis identification 
and management. See box 2 for some examples.
Knowledge on maternal sepsis and perception of enabling 
environments
At precampaign survey, 92% of respondents (1049/1144) 
had heard of maternal sepsis. However, only 16% (109/673) 
of respondents were able to correctly identify the definition 
criteria of maternal sepsis and 45% (114/251) identified 
the correct management for maternal sepsis. In addition, 
at precampaign, most survey respondents stated that their 
work environments were enabling for maternal sepsis 
identification and management: 78% (897/1155) stated 
that they felt confident of making right decisions, 79% 
(909/1155) that they perceived resources were available 
and 80% (921/1155) that they felt supported by their facil-
ities. See table 2 for overall results.
After campaign implementation there was a significant 
decrease in respondents who stated not having heard of 
maternal sepsis (−63.4% change; OR 0.35, 95% CI 0.18 to 
0.68). There was also a significant increase in perceived 
confidence in making right decisions with regard to 
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Table 2 Respondent knowledge on maternal sepsis and perception of enabling environments for maternal sepsis 









Knowledge on maternal sepsis
  Had not heard of maternal sepsis§ 95/1144 (8.3) 31/1021 (3.0) 0.35* (0.18 to 0.68) −63.4
  Correctly identified the two criteria to define maternal 
sepsis¶
109/673 (16.2) 74/647 (11.4) 0.67 (0.43 to 1.17) −29.4
  Correctly identified management of sepsis when 
maternal sepsis was suspected**
114/251 (45.4) 142/239 (59.4) 1.76 (0.73 to 4.21) 30.8
Perception of enabling environment for maternal sepsis identification and management
  Confident of making right decisions 897/1155 (77.7) 861/1033 (83.4) 1.44* (1.01 to 2.06) 7.3
  Resources available to make right decisions 909/1155 (78.7) 814/1033 (78.8) 1.01 (0.68 to 1.49) 0.1
  Supported by facility in making right decisions 921/1155 (79.7) 840/1033 (81.3) 1.11 (0.80 to 1.54) 2.0
Percentage change: [(% in post − % in pre)/% in pre]×100.
*P<0.05.
†Refers to OR between precampaign and postcampaign; OR calculated clustering at the geographical area level.
‡Reference group: precampaign.
§Responded No to the question ‘Have you ever heard of the term maternal sepsis?’
¶Answered Infection and Organ Dysfunction to the question: ‘What two criteria best describe maternal sepsis?’
**Answered Fluids and Antibiotics to the question: ‘What would be the first two things a woman should receive?’, when the respondent answered 
Infection/Sepsis to the question: ‘What would you first think could be causing her to feel this way?’
cOR, crude OR.
maternal sepsis identification and management (7.3% 
change; OR 1.44, 95% CI 1.01 to 2.06), although this level 
was quite high at precampaign (78%). There was a slight 
increase in respondents’ ability to identify the correct 
management when maternal sepsis was suspected after the 
implementation of the campaign, but this was not statisti-
cally significant (30.8% change; OR 1.76, 95% CI 0.73 to 
4.21). See online supplementary appendix 4a,b for these 
results according to respondent and facility characteristics.
After controlling for respondent and facility characteris-
tics, being a physician, having less than 10 years of experi-
ence and working in a level III facility were associated with 
decreased odds of not having heard of maternal sepsis at 
precampaign (table 3). Respondents from facilities that 
had implemented an expanded version of the campaign 
were more likely to have heard of maternal sepsis and iden-
tify the correct management of maternal sepsis at postcam-
paign. Respondents with less than 10 years of experience 
were more likely to have heard of maternal sepsis at precam-
paign, but there were no differences across providers with 
different years of experience after the campaign.
Physicians were more likely to respond that they felt 
confident in making the right decisions at postcampaign, 
while being a physician and having more than 20 years of 
experience had a significant interaction with time of the 
survey with regard to perception of availability of resources 
and support from their facilities. At precampaign and post-
campaign, respondents with 20 years or more of experi-
ence were more likely to perceive availability of resources 
for making right decisions and to feel supported by their 
facilities and these differences between groups were signif-
icant after the campaign (table 4). No differences in the 
perception of enabling environments were seen among 
respondents from facilities that had implemented an 
expanded version of the campaign.
DIsCussIOn
To the best of our knowledge, this is the first study to assess 
impact of an awareness campaign aimed at healthcare 
providers and implemented at a global level where precam-
paign and postcampaign data were collected in addition to 
measures relating to campaign recognition and exposure. 
Most healthcare providers stated that the campaign helped 
increase awareness of maternal sepsis and motivated them 
to do something differently, particularly to suspect maternal 
sepsis and act faster. Reports from the field also support this 
finding that exposure to the campaign increased sensiti-
sation to maternal infections and sepsis. Moreover, most 
survey respondents had heard of maternal sepsis even 
before campaign implementation; after the campaign 
this increased significantly. Although most respondents 
perceived their enabling environments in a positive way 
before campaign implementation, there was an increase 
in respondent confidence to make the right decisions 
regarding maternal sepsis identification and management 
after campaign implementation.
The STOP SEPSIS! awareness campaign implementation 
was effective with regard to respondents’ recognition of 
and exposure to the campaign; other campaign evalua-
tions have used these measures to positively assess short- 
term impact of campaigns.24–26 Furthermore, consistent 
and repeat exposure to campaign messaging has shown to 
increase awareness14; while exposure was only measured 
over the course of this evaluation period corresponding 
to the intended implementation period of the campaign, 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10 Brizuela V, et al. BMJ Open 2020;10:e036338. doi:10.1136/bmjopen-2019-036338
Open access 
the fact that most respondents stated the campaign raised 
awareness is a promising trend in the right direction.
Overall knowledge about maternal sepsis increased from 
precampaign to postcampaign implementation among 
respondents to our survey with regard to having heard 
about maternal sepsis. Our finding that overall knowledge 
increased is supported by existing literature that suggests 
that campaigns can increase knowledge on a specific topic 
among healthcare providers15 27 28 as well as among the 
general population.24 29 30 The fact that there was a slight 
increase in identifying the correct management of maternal 
sepsis is important. Research has shown that knowing what 
is needed to manage maternal sepsis correctly and early 
management of maternal sepsis are critical to implementing 
any changes in providers’ behaviour and improving 
maternal health outcomes.6 31 32 The low number of 
providers able to identify the two criteria defining maternal 
sepsis might be more a reflection of the lack of consensus on 
this condition prior to 2017, rather than a shortcoming of 
the campaign.12 The GLOSS awareness campaign was asso-
ciated with reducing differences among groups of health-
care providers depending on their qualifications or years 
of experience. This speaks to the importance of including 
healthcare providers with different qualifications and years 
of experience in awareness raising efforts.
We found there were overall increases in respondent 
confidence in making right decisions about maternal sepsis 
identification and management, but no significant changes 
with regard to overall respondent perception of availability 
of necessary resources and feeling supported by their facil-
ities. Evidence shows that confidence can affect clinical 
performance33 and that high levels of confidence among 
healthcare providers can have a positive impact on patients’ 
perception of experience of care.34 However, the change in 
perception of availability of resources and support limited to 
physicians and more experienced providers raises a broader 
question on actions that facilities need to take to empower 
all healthcare workers in feeling that they have the necessary 
resources and feel supported to provide quality care. This 
is especially important if we consider that a more restrictive 
definition of enabling environments results in much lower 
overall levels of perceived confidence, perception of avail-
ability of resources and feeling of support. Perceived lack of 
availability of resources may also be a product of increased 
awareness of what is necessary to address maternal sepsis. 
These findings are a call to hospital administrators and poli-
cymakers to foster enabling environments and secure avail-
ability and access to life- saving resources.
Sepsis awareness is gaining traction on global agendas4 10 17; 
this is supported by evidence from two studies looking at 
internet searches on sepsis,35 36 meaning increases resulting 
from this campaign could be responding to natural trends 
or other factors. It is also possible that awareness was raised 
by having participated in the research study and not neces-
sarily because of the campaign; disentangling the effect 
of the campaign from that of the implementation of the 
research study was impossible. Understanding whether any 
of these changes are sustained over time would provide 
us with further information on the lasting effects of the 
campaign.
Literature shows that while a campaign can help in 
raising awareness, it is insufficient in allowing for changes 
in behaviour.14 20 While behaviour change is important in 
impacting population- level health, it is one of many compo-
nents needed to make significant improvements; evidence 
from this study, similar to others, highlights the need for 
health system improvements such as availability of critical 
resources and support to improve maternal outcomes.37 
Assessing the impact that increased awareness resulting 
from a campaign has on behaviour change would provide 
us with supporting evidence that campaigns can help in 
improving health outcomes.
This study has some limitations. First, we used a precam-
paign/postcampaign methodology with no control group 
which does not allow to discern the impact of the campaign 
alone. Second, the method used to disseminate the survey 
and the fact that surveys were anonymous made it impos-
sible to match responses at precampaign and postcam-
paign. Surveys were anonymous to encourage providers 
to respond and remove potential response bias. However, 
it is to note that characteristics of participants at precam-
paign and postcampaign were similar. Third, because 
implementation of the campaign was left up to country 
coordinators, campaign fidelity was only assessed through 
healthcare provider self- report at postcampaign surveys. 
Fourth, this evaluation was restricted to the duration of 
the study follow- up period, hence providing insight into 
early findings only and limiting our knowledge of lasting 
impact of the campaign, which was beyond the goal of this 
activity. However, our findings suggest that campaigns can 
have at least short- term effects on provider’s knowledge 
and confidence. The positive perception of the campaign 
materials is encouraging. And fifth, since baseline data were 
collected after the soft launch of the campaign, the effect 
of the campaign may have been minimised because aware-
ness had already been increased through exposure to the 
online congress as well as other global activities on sepsis 
conducted by other groups. However, we know that less 
than 20% of respondents participated in the congress.
Our findings have implications for both practice and 
research. On the one hand, there appear to be benefits 
to coupling large multicountry studies with awareness 
campaigns. A campaign targeting healthcare providers can 
promote their engagement with research studies being 
conducted, potentially improving study outcomes. There 
is also evidence that including an awareness campaign 
creates an environment prime to implementing changes 
to clinical practice as per research study protocol. On the 
other hand, there is a clear need for additional research to 
identify lasting effects of awareness campaigns, especially as 
global initiatives focus on increasing awareness on maternal 
health issues.
A campaign designed to raise awareness among health-
care providers working in facilities participating in a global 
research study was associated with an increase in having 
heard of maternal sepsis, as well as increased provider 
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perception of confidence in making correct decisions. 
Offering healthcare providers with the information to 
make accurate and timely decisions while promoting envi-
ronments that enable self- confidence and support could 
improve maternal sepsis identification and management, 
which can ultimately have an impact on maternal health 
outcomes.
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